The Ordinary AHA 30% + BHA 2% Peeling Solution vs Paula's Choice SKIN PERFECTING 2% BHA Liquid Exfoliant
4 shared ingredients · The Ordinary AHA 30% + BHA 2% Peeling Solution 20 ingredients · Paula's Choice SKIN PERFECTING 2% BHA Liquid Exfoliant 4 ingredients
Where the two ingredient lists differ
The Ordinary AHA 30% + BHA 2% Peeling Solution · 20
- Glycolic acid
- Aloe Barbadensis Leaf Water
- Daucus Carota Sativa Extract
- PROPANEDIOL
- Cocamidopropyl Dimethylamine
- Lactic Acid
- Tartaric Acid
- CITRIC ACID
- PANTHENOL
- Sodium Hyaluronate Crosspolymer
- Tasmannia Lanceolata Fruit/Leaf Extract
- GLYCERIN
- PENTYLENE GLYCOL
- Xanthan Gum
- TRISODIUM ETHYLENEDIAMINE DISUCCINATE
- POTASSIUM SORBATE
- SODIUM BENZOATE
- ETHYLHEXYLGLYCERIN
- 1,2-HEXANEDIOL
- CAPRYLYL GLYCOL
Paula's Choice SKIN PERFECTING 2% BHA Liquid Exfoliant · 4
What has been studied about those differences
The Ordinary AHA 30% + BHA 2% Peeling Solution
- Glycolic acid Skin effectComparative study of buffered 50% glycolic acid (pH 3.0) + 0.5% salicylic acid solution vs Jessner's solution in patients with acne vulgaris
In a prospective, randomized, evaluator-blind, split-face trial of 20 patients with acne vulgaris, two 50% glycolic acid + 0.5% salicylic acid peels significantly reduced total lesion count (P<0.001) and produced fewer side effects than Jessner's solution.
Human trial · 2018 · 20 people · patients with acne vulgaris · Patients with acne vulgaris receiving two 50% glycolic acid + 0.5% salicylic acid peels 2 weeks apart (one side vs Jessner's solution on the other). · Small sample (20) and a combination peel (glycolic + salicylic acid); this is a procedural peel.
- Glycolic acid Skin effectShake-Induced Temporary Ion-Pairing Between Lecithin and Glycolic Acid for Enhanced Exfoliation in a Novel Biphasic Serum: Comparative Ex Vivo and in Vivo Randomised Studies
In a 2-week double-blind split-face study of 37 participants, a biphasic serum with 10% glycolic acid delivered 45.52% greater exfoliation (p<0.001) and improved skin brightness, texture and hydration versus the comparison side.
Human trial · 2026 · 37 people · participants in a split-face study · Healthy participants using a 10% glycolic acid biphasic serum on one side of the face for 2 weeks. · Short duration (2 weeks) and a single product formulation; the study measured exfoliation and cosmetic parameters.
- PANTHENOL Skin effectThe Effectiveness and Safety of a Skin Care Product With Centella asiatica Leaf Extract, Ceramide NP, and Panthenol in Subjects With Sensitive Skin: A Prospective, Observational Study
In 88 women with sensitive skin, a face cream containing Centella asiatica leaf extract, ceramide NP and panthenol lowered the SS-10 symptom score by 66% at week 2 and 76% at week 4, with irritation, tautness, itching and redness all significantly reduced.
Human trial · 2025 · 88 people · women with sensitive skin · Chinese women with sensitive skin applying the cream to the whole face, followed up at day 2, weeks 1, 2 and 4. · Observational and self-controlled.
- PANTHENOL Skin effectA cream containing linoleic acid, 5% dexpanthenol and ceramide in the treatment of atopic dermatitis
In 38 children with atopic dermatitis, a cream containing linoleic acid, 5% dexpanthenol and ceramide improved SCORAD significantly more than a 5% urea cream after 4 weeks (P = 0.043); both groups improved from baseline.
Human trial · 2024 · 38 people · children with atopic dermatitis (37 completed) · Children with mild-to-moderate atopic dermatitis applying the cream twice daily for 4 weeks in a randomised, double-blind, bilateral paired design. · Both interventions were non-prescription moisturisers: this is emollient / basic skin care. Small sample (37 completed); stratum corneum hydration and time to remission stayed close between groups.
The situations those studies looked at
What to watch for
The Ordinary AHA 30% + BHA 2% Peeling Solution
- SALICYLIC ACID IrritationTopical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Trials of topical salicylic acid for acne reported application-site reactions such as scaling and redness.
Review article · 2020 · People with mild to moderate acne in the included trials · Topical salicylic acid in acne trials, mainly leave-on use over eight weeks or longer. · The review graded the salicylic acid adverse-event comparisons as very low certainty.
- PANTHENOL SensitizationPantothenic Acid as an Unexpected Cause of Hypersensitivity to Sensitive or Atopic Skin Care Products - A Narrative Review
Panthenol is treated as non-allergenic, this review argues that frequent exposure, especially on damaged skin, can produce hypersensitivity to it. The likely route is a delayed (type IV) contact reaction; immediate and mixed reactions remain possible. Proposes patch testing with the patient's own product and with panthenol 5% in petrolatum.
Review article · 2026 · People with atopic or damaged skin using panthenol-containing products · People who use panthenol products repeatedly, particularly those with atopic or damaged skin - the group the author says is most exposed. · A single-author narrative review. The mechanism it proposes is stated as likely. Read it as a reason to keep panthenol on the list of possible allergens.
Paula's Choice SKIN PERFECTING 2% BHA Liquid Exfoliant
- SALICYLIC ACID IrritationTopical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Trials of topical salicylic acid for acne reported application-site reactions such as scaling and redness.
Review article · 2020 · People with mild to moderate acne in the included trials · Topical salicylic acid in acne trials, mainly leave-on use over eight weeks or longer. · The review graded the salicylic acid adverse-event comparisons as very low certainty.
Both ingredient lists and where they came from
Ingredient list from: AHA 30% + BHA 2% Peeling Solution — brand product page · last checked 2026-10-30
Ingredient list from: Paula's Choice SKIN PERFECTING 2% BHA Liquid Exfoliant — brand product page · last checked 2026-10-30